Cancer patients

Cancer research

Bladder Cancer Treatment Outcomes: New Study Finds Gem/doce Therapy More Effective Than Additional BCG in BCG-Unresponsive Patients

Researchers from the University of Texas Southwestern Medical Center have conducted a study comparing oncologic outcomes between sequential intravesical gemcitabine and docetaxel (gem/doce) versus additional bacillus Calmette-Guérin (BCG) in patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). The study, published in European Urology Oncology, aimed to determine which treatment